全文获取类型
收费全文 | 23554篇 |
免费 | 956篇 |
国内免费 | 523篇 |
专业分类
耳鼻咽喉 | 586篇 |
儿科学 | 746篇 |
妇产科学 | 228篇 |
基础医学 | 2633篇 |
口腔科学 | 283篇 |
临床医学 | 1288篇 |
内科学 | 4047篇 |
皮肤病学 | 762篇 |
神经病学 | 2786篇 |
特种医学 | 1200篇 |
外科学 | 3246篇 |
综合类 | 1850篇 |
预防医学 | 568篇 |
眼科学 | 547篇 |
药学 | 3203篇 |
4篇 | |
中国医学 | 579篇 |
肿瘤学 | 477篇 |
出版年
2024年 | 19篇 |
2023年 | 149篇 |
2022年 | 389篇 |
2021年 | 611篇 |
2020年 | 264篇 |
2019年 | 469篇 |
2018年 | 565篇 |
2017年 | 473篇 |
2016年 | 380篇 |
2015年 | 409篇 |
2014年 | 652篇 |
2013年 | 1011篇 |
2012年 | 647篇 |
2011年 | 753篇 |
2010年 | 695篇 |
2009年 | 769篇 |
2008年 | 918篇 |
2007年 | 889篇 |
2006年 | 655篇 |
2005年 | 591篇 |
2004年 | 623篇 |
2003年 | 746篇 |
2002年 | 1457篇 |
2001年 | 1769篇 |
2000年 | 1992篇 |
1999年 | 1322篇 |
1998年 | 1352篇 |
1997年 | 1223篇 |
1996年 | 720篇 |
1995年 | 386篇 |
1994年 | 292篇 |
1993年 | 211篇 |
1992年 | 210篇 |
1991年 | 202篇 |
1990年 | 146篇 |
1989年 | 170篇 |
1988年 | 119篇 |
1987年 | 116篇 |
1986年 | 107篇 |
1985年 | 114篇 |
1984年 | 78篇 |
1983年 | 68篇 |
1982年 | 61篇 |
1981年 | 40篇 |
1980年 | 32篇 |
1979年 | 20篇 |
1977年 | 24篇 |
1976年 | 17篇 |
1973年 | 21篇 |
1971年 | 21篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
《Anaesthesia and Intensive Care Medicine》2020,21(11):572-577
Phaeochromocytomas and paragangliomas (PPGL) are catecholamine-secreting neuroendocrine tumours. These tumours may be identified incidentally, as part of a work-up for multiple endocrine neoplasia or following haemodynamic surges during unrelated procedures. Advances in preoperative management and improved management of intraoperative haemodynamic instability have significantly reduced surgical mortality from around 40% to less than 3%. Surgery is the definitive treatment in most cases and laparoscopic resection where possible is associated with improved outcomes. Anaesthetic management of PPGL cases represents a unique haemodynamic challenge both before, during and after tumour resection. In this article we describe the physiology of these tumours, their diagnosis, preoperative optimization methods, intraoperative anaesthetic management and management of postoperative complications. 相似文献
3.
4.
《Clinical neurophysiology》2021,132(12):3104-3115
ObjectiveWe aimed to establish an objective neurophysiological test protocol that can be used to assess the somatosensory nervous system.MethodsIn order to assess most fiber subtypes of the somatosensory nervous system, repetitive stimuli of seven different modalities (touch, vibration, pinprick, cold, contact heat, laser, and warmth) were synchronized with the electroencephalogram (EEG) and applied on the cheek and dorsum of the hand and dorsum of the foot in 21 healthy subjects and three polyneuropathy (PNP) patients. Latencies and amplitudes of the modalities were assessed and compared. Patients received quantitative sensory testing (QST) as reference.ResultsWe found reproducible evoked potentials recordings for touch, vibration, pinprick, contact-heat, and laser stimuli. The recording of warm-evoked potentials was challenging in young healthy subjects and not applicable in patients. Latencies were shortest within Aβ-fiber-mediated signals and longest within C-fibers. The test protocol detected function loss within the Aβ-fiber and Aδ-fiber-range in PNP patients. This function loss corresponded with QST findings.ConclusionIn this pilot study, we developed a neurophysiological test protocol that can specifically assess most of the somatosensory modalities. Despite technical challenges, initial patient data appear promising regarding a possible future clinical application.SignificanceEstablished and custom-made stimulators were combined to assess different fiber subtypes of the somatosensory nervous system using modality-specific evoked potentials. 相似文献
5.
目的:探讨改良大骨瓣联合软通道微创介入逐渐减压术治疗重型颅脑损伤的疗效。方法方便选择自2009年12月—2014年11月该院收治的重型颅脑损伤病例70例,随机分为改良组和对照组2组,每组35例,改良组施行改良大骨瓣联合软通道微创介入逐渐减压术,对照组按标准大骨瓣开颅、硬脑膜一次性全切开,对比分析两组的并发症发生率及预后。结果改良组发生迟发性颅内血肿、大面积脑梗塞及弥漫性脑肿胀等并发症9例(25.7%,9/35),预后良好者23例(65.7%,23/35),对照组发生并发症19例(54.3%,19/35),预后良好者14例(40.0%,14/35),两组并发症发生率和预后差异具有统计学意义(P<0.05)。结论改良大骨瓣联合软通道微创介入逐渐减压术治疗重型颅脑损伤,效果良好,显著降低死亡率。 相似文献
6.
7.
《Drug discovery today》2022,27(6):1733-1742
Compounds that exhibit assay interference or undesirable mechanisms of bioactivity are routinely encountered in assays at various stages of drug discovery. We observed that assays for the investigation of thiol-reactive and redox-active compounds have not been collected in a comprehensive review. Here, we review these assays and subject them to experimental optimization to improve their reliability. We demonstrate the usefulness of our assay cascade by assaying a library of bioactive compounds, chemical probes, and a set of approved drugs. These high-throughput assays should complement the array of wet-lab and in silico assays during the initial stages of hit discovery campaigns to pursue only hit compounds with tractable mechanisms of action. 相似文献
8.
9.
Michael M Gezalian Luigi Mangiacotti Padmesh Rajput Nicklaus Sparrow Konrad Schlick Shouri Lahiri 《Journal of cerebral blood flow and metabolism》2021,41(4):693
Adrenoceptor and calcium channel modulating medications are widely used in clinical practice for acute neurological and systemic conditions. It is generally assumed that the cerebrovascular effects of these drugs mirror that of their systemic effects – and this is reflected in how these medications are currently used in clinical practice. However, recent research suggests that there are distinct cerebrovascular-specific effects of these medications that are related to the unique characteristics of the cerebrovascular anatomy including the regional heterogeneity in density and distribution of adrenoceptor subtypes and calcium channels along the cerebrovasculature. In this review, we critically evaluate existing basic science and clinical research to discuss known and putative interactions between adrenoceptor and calcium channel modulating pharmacotherapies, the neurovascular unit, and cerebrovascular anatomy. In doing so, we provide a rationale for selecting vasoactive medications based on lesion location and lay a foundation for future investigations that will define neuroprotective paradigms of adrenoceptor and calcium channel modulating therapies to improve neurological outcomes in acute neurological and systemic disorders. 相似文献
10.